Intensity Therapeutics, Inc.INTSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.5%
5Y CAGR+18.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+21.5%/yr
Annual compound
5Y CAGR
+18.8%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $10.50M | +119.3% |
| 2023 | $4.79M | -6.7% |
| 2022 | $5.13M | -12.4% |
| 2021 | $5.86M | +16.0% |
| 2020 | $5.05M | +13.8% |
| 2019 | $4.44M | - |